See All Resources
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio- Oncology Society
Go to Resource
Share:
Link is copied!
Originally Published:
March 28, 2024
